Information
-
Trademark
-
90301364
-
International Classifications
-
Filing Date
November 05, 2020
3 years ago
-
Transaction Date
April 23, 2024
a month ago
-
Status Date
February 26, 2024
3 months ago
-
Published for Opposition Date
May 24, 2022
2 years ago
-
Location Date
February 26, 2024
3 months ago
-
Status Code
732
-
Current Location
DIVISIONAL UNIT
Employee Name
EULIN, INGRID C
-
Attorney Docket Number
3309.0340000
Attorney Name
TRACY-GENE G. DURKIN
Law Office Assigned Location Code
L50
-
Owners
Mark Drawing Code
3
Mark Identification
ADC THERAPEUTICS
Case File Statements
- DM0000: The mark consists of the letters "ADC" above the word "THERAPEUTICS". A wave element extends across the letter "A" to a shared edge of the letters "D" and "C".
- GS0051: Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
- DS0000: "THERAPEUTICS"
Case File Event Statements
-
11/9/2020 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/6/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/7/2021 - 3 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
2/2/2021 - 3 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/6/2021 - 3 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/6/2021 - 3 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/6/2021 - 3 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
8/5/2021 - 2 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
8/5/2021 - 2 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/6/2021 - 2 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/6/2021 - 2 years ago
11 - FINAL REFUSAL WRITTEN
Type: CNFR
-
10/6/2021 - 2 years ago
12 - FINAL REFUSAL E-MAILED
Type: GNFR
-
10/6/2021 - 2 years ago
13 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
4/6/2022 - 2 years ago
14 - EXPARTE APPEAL RECEIVED AT TTAB
Type: EXAF
-
4/6/2022 - 2 years ago
15 - JURISDICTION RESTORED TO EXAMINING ATTORNEY
Type: JURT
-
4/6/2022 - 2 years ago
16 - EX PARTE APPEAL-INSTITUTED
Type: EXPI
-
4/6/2022 - 2 years ago
17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
4/7/2022 - 2 years ago
18 - ASSIGNED TO LIE
Type: ALIE
-
4/12/2022 - 2 years ago
19 - ASSIGNED TO LIE
Type: ALIE
-
4/13/2022 - 2 years ago
20 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/13/2022 - 2 years ago
21 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/20/2022 - 2 years ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/20/2022 - 2 years ago
23 - EXPARTE APPEAL TERMINATED
Type: EXPT
-
5/4/2022 - 2 years ago
24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/24/2022 - 2 years ago
25 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/24/2022 - 2 years ago
26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/19/2022 - a year ago
27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
1/18/2023 - a year ago
28 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/18/2023 - a year ago
29 - SOU EXTENSION 1 FILED
Type: EXT1
-
1/18/2023 - a year ago
30 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
1/20/2023 - a year ago
31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
7/13/2023 - 10 months ago
32 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
7/13/2023 - 10 months ago
33 - SOU EXTENSION 2 FILED
Type: EXT2
-
7/13/2023 - 10 months ago
34 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
7/15/2023 - 10 months ago
35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/18/2024 - 4 months ago
39 - DIVISIONAL REQUEST RECEIVED
Type: DRRR
-
1/18/2024 - 4 months ago
41 - SOU EXTENSION 3 FILED
Type: EXT3
-
1/18/2024 - 4 months ago
36 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/18/2024 - 4 months ago
37 - TEAS REQUEST TO DIVIDE RECEIVED
Type: ERTD
-
2/5/2024 - 3 months ago
38 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
2/26/2024 - 3 months ago
40 - DIVISIONAL PROCESSING COMPLETE
Type: DPCC
-
2/27/2024 - 3 months ago
43 - CORRECTED NOA E-MAILED
Type: NOAC
-
2/26/2024 - 3 months ago
42 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
2/27/2024 - 3 months ago
44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA